Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Original Study: Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhotic Patients.

Tabchouri N, Barbier L, Menahem B, Perarnau JM, Muscari F, Fares N, D'Alteroche L, Valette PJ, Dumortier J, Alves A, Lubrano J, Bureau C, Salamé E.

J Gastrointest Surg. 2019 Feb 28. doi: 10.1007/s11605-018-4053-x. [Epub ahead of print]

PMID:
30820792
2.

Pregnancy and donor-specific HLA-antibody-mediated rejection after liver transplantation: "Liaisons dangereuses"?

Dumortier J, Dedic T, Erard-Poinsot D, Rivet C, Guillaud O, Chambon-Augoyard C, Bosch A, Lachaux A, Couchonnal E, Thaunat O, Boillot O, Dubois V.

Transpl Immunol. 2019 Feb 8. pii: S0966-3274(18)30137-0. doi: 10.1016/j.trim.2019.02.002. [Epub ahead of print]

PMID:
30743001
3.

Assessment of liver fibrosis by transient elastography (Fibroscan®) in patients with A1AT deficiency.

Guillaud O, Dumortier J, Traclet J, Restier L, Joly P, Chapuis-Cellier C, Lachaux A, Mornex JF.

Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):77-81. doi: 10.1016/j.clinre.2018.08.016. Epub 2019 Jan 3.

PMID:
30612958
4.

A practical approach to tuberculosis diagnosis and treatment in liver transplant recipients in a low-prevalence area.

Bosch A, Valour F, Dumitrescu O, Dumortier J, Radenne S, Pages-Ecochard M, Chidiac C, Ferry T, Perpoint T, Miailhes P, Conrad A, Goutelle S, Ader F; Lyon TB study Group.

Med Mal Infect. 2018 Dec 24. pii: S0399-077X(17)31041-7. doi: 10.1016/j.medmal.2018.11.013. [Epub ahead of print] Review.

PMID:
30591271
5.

Liver disease related to alpha1-antitrypsin deficiency in French children: The DEFI-ALPHA cohort.

Ruiz M, Lacaille F, Berthiller J, Joly P, Dumortier J, Aumar M, Bridoux-Henno L, Jacquemin E, Lamireau T, Broué P, Rivet C, Belmalih A, Restier L, Chapuis-Cellier C, Bouchecareilh M, Lachaux A; Groupe Francophone d’Hépatologie Gastroentérologie et Nutrition Pédiatriques.

Liver Int. 2018 Dec 27. doi: 10.1111/liv.14035. [Epub ahead of print]

PMID:
30589493
6.

Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.

Bergère M, Erard-Poinsot D, Boillot O, Valette PJ, Guillaud O, Chambon-Augoyard C, Dumortier J.

Clin Res Hepatol Gastroenterol. 2018 Dec 18. pii: S2210-7401(18)30268-7. doi: 10.1016/j.clinre.2018.11.011. [Epub ahead of print]

PMID:
30578107
7.

Recurrence of Hereditary Hemorrhagic Telangiectasia After Liver Transplantation: Clinical Implications and Physiopathological Insights.

Dumortier J, Dupuis-Girod S, Valette PJ, Valent A, Guillaud O, Saurin JC, Hervieu V, Robinson P, Plauchu H, Paliard P, Boillot O, Scoazec JY.

Hepatology. 2018 Dec 14. doi: 10.1002/hep.30424. [Epub ahead of print]

PMID:
30549294
8.

mTOR inhibitors in pediatric liver transplant recipients.

Dumortier J, Couchonnal E, Lacaille F, Rivet C, Debray D, Boillot O, Lachaux A, Ackermann O, Gonzales E, Wildhaber BE, Jacquemin E, McLin V.

Clin Res Hepatol Gastroenterol. 2018 Dec 6. pii: S2210-7401(18)30267-5. doi: 10.1016/j.clinre.2018.11.010. [Epub ahead of print]

PMID:
30528864
9.

Hyperammonemic encephalopathy associated with hereditary hemorrhagic telangiectasia.

Dumortier J, Guillaud O, Erard-Poinsot D, Dupuis-Girod S, Francoz C, Durand F.

Clin Res Hepatol Gastroenterol. 2018 Nov 14. pii: S2210-7401(18)30227-4. doi: 10.1016/j.clinre.2018.10.011. [Epub ahead of print] No abstract available.

PMID:
30447907
10.

De Novo Primary Liver Cancer After Liver Transplantation: A French National Study on 15803 Patients.

Allaire M, Sérée O, Coilly A, Houssel-Debry P, Neau-Cransac M, Pageaux GP, Dumortier J, Altieri M.

Exp Clin Transplant. 2018 Dec;16(6):779-780. doi: 10.6002/ect.2018.0222. Epub 2018 Nov 6. No abstract available.

11.

Class II Human Leukocyte Antigen Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation After Liver Transplantation.

Meszaros M, Dubois V, Niemann M, Ursic-Bedoya J, Faure S, Guillaud O, Boillot O, Pageaux GP, Thevenin C, Dumortier J.

Liver Transpl. 2019 Jan;25(1):184-185. doi: 10.1002/lt.25357. No abstract available.

PMID:
30329206
12.

Comprehensive user requirements engineering methodology for secure and interoperable health data exchange.

Natsiavas P, Rasmussen J, Voss-Knude M, Votis Κ, Coppolino L, Campegiani P, Cano I, Marí D, Faiella G, Clemente F, Nalin M, Grivas E, Stan O, Gelenbe E, Dumortier J, Petersen J, Tzovaras D, Romano L, Komnios I, Koutkias V.

BMC Med Inform Decis Mak. 2018 Oct 16;18(1):85. doi: 10.1186/s12911-018-0664-0.

13.

Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.

Montano-Loza AJ, Hansen BE, Corpechot C, Roccarina D, Thorburn D, Trivedi P, Hirschfield G, McDowell P, Poupon R, Dumortier J, Bosch A, Giostria E, Conti F, Parés A, Reig A, Floreani A, Russo FP, Goet JC, Harms MH, van Buuren H, Van den Ende N, Nevens F, Verhelst X, Donato MF, Malinverno F, Ebadi M, Mason AL; Global PBC Study Group.

Gastroenterology. 2019 Jan;156(1):96-107.e1. doi: 10.1053/j.gastro.2018.10.001. Epub 2018 Oct 6.

PMID:
30296431
14.

Evaluation of the accuracy of exchangeable copper and relative exchangeable copper (REC) in a mouse model of Wilson's disease.

Heissat S, Harel A, Um K, Brunet AS, Hervieu V, Guillaud O, Dumortier J, Lachaux A, Mintz E, Bost M.

J Trace Elem Med Biol. 2018 Dec;50:652-657. doi: 10.1016/j.jtemb.2018.06.013. Epub 2018 Jun 21.

PMID:
30269758
15.

De Novo Malignancies Screening After Liver Transplantation for Alcoholic Liver Disease: A Comparative Opportunistic Study.

Renaud L, Hilleret MN, Thimonier E, Guillaud O, Arbib F, Ferretti G, Jankowski A, Chambon-Augoyard C, Erard-Poinsot D, Decaens T, Boillot O, Leroy V, Dumortier J.

Liver Transpl. 2018 Dec;24(12):1690-1698. doi: 10.1002/lt.25336.

PMID:
30207421
16.

Total donor chimerism with bone marrow GVHD after multivisceral transplantation.

Alcazer V, Eljaafari A, Lebras L, Dubois V, Plesa A, Sobh M, Hot A, Dumortier J, Boillot O, Chambrier C, Michallet M.

Am J Hematol. 2018 Nov;93(11):E372-E374. doi: 10.1002/ajh.25253. Epub 2018 Sep 9. No abstract available.

PMID:
30113704
17.

Choledochoduodenostomy for the treatment of portal cavernoma biliary stenosis to avoid bloody ERCP.

Napoléon M, Dumortier J, Rostain F, Rivory J, Ponchon T, Gimonet H, Pioche M.

Endoscopy. 2018 Oct;50(10):E289-E291. doi: 10.1055/a-0651-0284. Epub 2018 Aug 10. No abstract available.

PMID:
30096719
18.

Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.

Sérée O, Altieri M, Guillaume E, De Mil R, Lobbedez T, Robinson P, Segol P, Salamé E, Abergel A, Boillot O, Conti F, Chazouillères O, Debette-Gratien M, Debray D, Hery G, Dharancy S, Durand F, Duvoux C, Francoz C, Gugenheim J, Hardwigsen J, Houssel-Debry P, Jacquemin E, Kamar N, Latournerie M, Lebray P, Leroy V, Mazzola A, Neau-Cransac M, Pageaux GP, Radenne S, Saliba F, Samuel D, Vanlemmens C, Woehl-Jaegle ML, Launoy G, Dumortier J.

Liver Transpl. 2018 Oct;24(10):1425-1436. doi: 10.1002/lt.25310.

PMID:
30021061
19.

Transjugular intrahepatic portosystemic shunt for alveolar echinococcosis of the liver and Budd-Chiari syndrome.

Dumortier J, Valette PJ.

Clin Res Hepatol Gastroenterol. 2018 Sep;42(4):e61-e62. doi: 10.1016/j.clinre.2017.11.007. Epub 2018 Jun 8. No abstract available.

PMID:
29891417
20.

Very late relapse of hepatitis C virus infection immediately after liver transplant.

Erard-Poinsot D, Scholtès C, Billoud C, Zoulim F, Dumortier J.

Am J Transplant. 2018 Oct;18(10):2587-2590. doi: 10.1111/ajt.14965. Epub 2018 Jul 2.

PMID:
29878644
21.

Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease.

Dumortier J, Maucort-Boulch D, Poinsot D, Thimonier E, Chambon-Augoyard C, Ducroux E, Vallin M, Walter T, Robinson P, Guillaud O, Boillot O.

Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):427-435. doi: 10.1016/j.clinre.2018.04.011. Epub 2018 May 31.

PMID:
29861393
22.

The epidemiology of Budd-Chiari syndrome in France.

Ollivier-Hourmand I, Allaire M, Goutte N, Morello R, Chagneau-Derrode C, Goria O, Dumortier J, Cervoni JP, Dharancy S, Ganne-Carrié N, Bureau C, Carbonell N, Abergel A, Nousbaum JB, Anty R, Barraud H, Ripault MP, De Ledinghen V, Minello A, Oberti F, Radenne S, Bendersky N, Farges O, Archambeaud I, Guillygomarc'h A, Ecochard M, Ozenne V, Hilleret MN, Nguyen-Khac E, Dauvois B, Perarnau JM, Lefilliatre P, Raabe JJ, Doffoel M, Becquart JP, Saillard E, Valla D, Dao T, Plessier A; French Network for Vascular Disorders of the Liver.

Dig Liver Dis. 2018 Sep;50(9):931-937. doi: 10.1016/j.dld.2018.04.004. Epub 2018 Apr 12.

PMID:
29803757
23.

Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study.

Allaire M, Cadranel JD, Bureau C, Zerkly S, Thévenot T, Garioud A, Cacoub P, Macaigne G, Alric L, Jouannaud V, Lison H, Chagneau-Derrode C, Pariente A, Pe Combining Acute Accent Laquier ACGAS, Bourlie Combining Grave Accent Re M, Causse X, Nousbaum JB, Dumortier JCAAR, Louvet A, Rosa-He Combining Acute Accent Zode I, Ganne-Carrie Combining Acute Accent N, Chentouh R, Sfaxi A, Gournay JCAAR, Blasco-Perrin HCAALCGAN, Antonini T, Spahr L, Bronowicki JP, Silvain C, Di Martino V, Grange JD, Denis J, Dupont K, Iaria P, Ollivier-Hourmand I, Dao T; French association of gastroenterologist and hepatologist from primary hospital (ANGH).

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1216-1223. doi: 10.1097/MEG.0000000000001155.

PMID:
29727379
24.

Prevalence, Risk Factors, and Impact of Donor-Specific Alloantibodies After Adult Liver Transplantation.

Vandevoorde K, Ducreux S, Bosch A, Guillaud O, Hervieu V, Chambon-Augoyard C, Poinsot D, André P, Scoazec JY, Robinson P, Boillot O, Dubois V, Dumortier J.

Liver Transpl. 2018 Aug;24(8):1091-1100. doi: 10.1002/lt.25177.

PMID:
29665189
25.

Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study.

Anty R, Favre G, Coilly A, Rossignol E, Houssel-Debry P, Duvoux C, De Ledinghen V, Di Martino V, Leroy V, Radenne S, Kamar N, Canva V, D'Alteroche L, Durand F, Dumortier J, Lebray P, Besch C, Tran A, Canivet CM, Botta-Fridlund D, Montialoux H, Moreno C, Conti F, Silvain C, Perré P, Habersetzer F, Abergel A, Debette-Gratien M, Dharancy S, Esnault VLM, Fougerou-Leurent C, Cagnot C, Diallo A, Veislinger A, Danjou H, Samuel D, Pageaux GP, Duclos-Vallée JC; ANRS CO23 CUPILT Study Group.

Aliment Pharmacol Ther. 2018 Jun;47(12):1682-1689. doi: 10.1111/apt.14639. Epub 2018 Apr 17.

PMID:
29665081
26.

Chronic Genotype 3 Hepatitis E in Pregnant Woman Receiving Infliximab and Azathioprine.

Charre C, Ramière C, Dumortier J, Abravanel F, Lhomme S, Gincul R, Scholtès C.

Emerg Infect Dis. 2018 May;24(5):941-943. doi: 10.3201/eid2405.171845.

27.

Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.

Altwegg R, Combes R, Laharie D, De Ledinghen V, Radenne S, Conti F, Chazouilleres O, Duvoux C, Dumortier J, Leroy V, Treton X, Durand F, Dharancy S, Nachury M, Goutorbe F, Lamblin G, Boivineau L, Peyrin-Biroulet L, Pageaux GP.

Dig Liver Dis. 2018 Jul;50(7):668-674. doi: 10.1016/j.dld.2018.02.014. Epub 2018 Mar 13.

PMID:
29655972
28.

12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation.

Houssel-Debry P, Coilly A, Fougerou-Leurent C, Jezequel C, Duvoux C, De Ledinghen V, Radenne S, Kamar N, Leroy V, Martino VD, D'Alteroche L, Canva V, Conti F, Dumortier J, Montialoux H, Lebray P, Botta-Fridlund D, Tran A, Moreno C, Silvain C, Besch C, Perre P, Francoz C, Abergel A, Habersetzer F, Debette-Gratien M, Cagnot C, Diallo A, Chevaliez S, Rossignol E, Veislinger A, Duclos-Vallee JC, Pageaux GP; the ANRS CO23 CUPILT study group.

Hepatology. 2018 Oct;68(4):1277-1287. doi: 10.1002/hep.29918.

PMID:
29633389
29.

[A developmental checkpoint synchronizes morphogenesis and cellular differentiation in mammalian embryos].

Dumortier JG, Maître JL.

Med Sci (Paris). 2018 Mar;34(3):205-207. doi: 10.1051/medsci/20183403005. Epub 2018 Mar 16. French. No abstract available.

30.

Impact of a first study of early transplantation in acute alcoholic hepatitis: Results of a nationwide survey in french liver transplantation programs.

Antonini TM, Guillaud O, Dumortier J, Dharancy S, Saliba F, Mathurin P, Duclos-Vallée JC, Duvoux C; for Groupe de Recherche Français en Greffe de Foie (GReF2).

Liver Transpl. 2018 Jun;24(6):841-844. doi: 10.1002/lt.25039. Epub 2018 May 13. No abstract available.

PMID:
29476690
31.

Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.

Funk-Debleds P, Ducroux E, Guillaud O, Ursic-Bedoya J, Decullier E, Vallin M, Euvrard S, Pageaux GP, Boillot O, Dumortier J.

J Am Acad Dermatol. 2018 Jul;79(1):84-91. doi: 10.1016/j.jaad.2017.12.063. Epub 2018 Jan 4.

PMID:
29307647
32.

Early embryos kept in check.

Dumortier JG, Maître JL.

Nature. 2017 Dec 14;552(7684):178-179. doi: 10.1038/d41586-017-07436-w. No abstract available.

PMID:
29239372
33.

Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.

Reymond M, Barbier L, Salame E, Besh C, Dumortier J, Pageaux GP, Bureau C, Dharancy S, Vanlemmens C, Abergel A, Woehl Jaegle ML, Magro P, Patat F, Laurent E, Perarnau JM.

Transplantation. 2018 Apr;102(4):616-622. doi: 10.1097/TP.0000000000001981.

PMID:
29077657
34.

Sleep, training load and performance in elite female gymnasts.

Dumortier J, Mariman A, Boone J, Delesie L, Tobback E, Vogelaers D, Bourgois JG.

Eur J Sport Sci. 2018 Mar;18(2):151-161. doi: 10.1080/17461391.2017.1389992. Epub 2017 Oct 26.

PMID:
29072537
35.

Biliary stenosis after transjugular intrahepatic portosystemic shunt.

Dumortier J, Pioche M, Muller A, Ponchon T, Henry L, Valette PJ, Cuminal L.

Clin Res Hepatol Gastroenterol. 2018 Feb;42(1):e19-e21. doi: 10.1016/j.clinre.2017.07.005. Epub 2017 Oct 3. No abstract available.

PMID:
28986125
36.

Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study.

Dharancy S, Coilly A, Fougerou-Leurent C, Duvoux C, Kamar N, Leroy V, Tran A, Houssel-Debry P, Canva V, Moreno C, Conti F, Dumortier J, Di Martino V, Radenne S, De Ledinghen V, D'Alteroche L, Silvain C, Besch C, Perré P, Botta-Fridlund D, Francoz C, Habersetzer F, Montialoux H, Abergel A, Debette-Gratien M, Rohel A, Rossignol E, Samuel D, Duclos-Vallée JC, Pageaux GP; ANRS CO23 CUPILT study group.

Am J Transplant. 2017 Nov;17(11):2869-2878. doi: 10.1111/ajt.14490. Epub 2017 Oct 19.

37.

Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients After Liver Transplantation: Results From the ANRS CO23 CUPILT Study.

Antonini TM, Coilly A, Rossignol E, Fougerou-Leurent C, Dumortier J, Leroy V, Veislinger A, Radenne S, Botta-Fridlund D, Durand F, Houssel-Debry P, Kamar N, Canva V, Perré P, De Ledinghen V, Rohel A, Diallo A, Taburet AM, Samuel D, Pageaux GP, Duclos-Vallée JC; ANRS C023 CUPILT study group.

Transplantation. 2018 Jan;102(1):119-126. doi: 10.1097/TP.0000000000001928.

PMID:
28846559
38.

Te-based chalcogenide materials for selector applications.

Velea A, Opsomer K, Devulder W, Dumortier J, Fan J, Detavernier C, Jurczak M, Govoreanu B.

Sci Rep. 2017 Aug 14;7(1):8103. doi: 10.1038/s41598-017-08251-z.

39.

Deleterious impact of C3d-binding donor-specific anti-HLA antibodies after pediatric liver transplantation.

Couchonnal E, Rivet C, Ducreux S, Dumortier J, Bosch A, Boillot O, Collardeau-Frachon S, Dubois R, Hervieu V, André P, Scoazec JY, Lachaux A, Dubois V, Guillaud O.

Transpl Immunol. 2017 Dec;45:8-14. doi: 10.1016/j.trim.2017.08.001. Epub 2017 Aug 3.

PMID:
28782692
40.

Relative exchangeable copper: A valuable tool for the diagnosis of Wilson disease.

Guillaud O, Brunet AS, Mallet I, Dumortier J, Pelosse M, Heissat S, Rivet C, Lachaux A, Bost M.

Liver Int. 2018 Feb;38(2):350-357. doi: 10.1111/liv.13520. Epub 2017 Aug 23.

PMID:
28719006
41.

Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients.

Altieri M, Delaval G, Kimmoun E, Allaire M, Salamé E, Dumortier J.

Exp Clin Transplant. 2018 Jun;16(3):321-325. doi: 10.6002/ect.2016.0328. Epub 2017 Jul 11.

42.

Gastrointestinal stromal tumors (GIST) presenting in the liver: Diagnostic, prognostic and therapeutic issues.

Joyon N, Dumortier J, Aline-Fardin A, Caramella C, Valette PJ, Blay JY, Scoazec JY, Dartigues P.

Clin Res Hepatol Gastroenterol. 2018 Apr;42(2):e23-e28. doi: 10.1016/j.clinre.2017.05.010. Epub 2017 Jun 20.

PMID:
28645742
43.

Portal Vein Thrombosis and Nephrotic Syndrome After Liver Transplant.

Dumortier J, Sicard A, Guillaud O, Valette PJ, Scoazec JY, Boillot O.

Exp Clin Transplant. 2017 Jun 5. doi: 10.6002/ect.2016.0259. [Epub ahead of print]

44.

Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey.

Dumortier J, Cottin J, Lavie C, Guillaud O, Hervieu V, Chambon-Augoyard C, Scoazec JY, Vukusic S, Vial T.

Clin Res Hepatol Gastroenterol. 2017 Sep;41(4):497-501. doi: 10.1016/j.clinre.2017.03.008. Epub 2017 Apr 21.

PMID:
28438569
45.

Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis.

Herrmann E, de Lédinghen V, Cassinotto C, Chu WC, Leung VY, Ferraioli G, Filice C, Castera L, Vilgrain V, Ronot M, Dumortier J, Guibal A, Pol S, Trebicka J, Jansen C, Strassburg C, Zheng R, Zheng J, Francque S, Vanwolleghem T, Vonghia L, Manesis EK, Zoumpoulis P, Sporea I, Thiele M, Krag A, Cohen-Bacrie C, Criton A, Gay J, Deffieux T, Friedrich-Rust M.

Hepatology. 2018 Jan;67(1):260-272. doi: 10.1002/hep.29179. Epub 2017 Nov 15. Review.

46.

Survival and prognostic factors after adjuvant 131iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 years.

Olesinski J, Mithieux F, Guillaud O, Hilleret MN, Lombard-Bohas C, Henry L, Boillot O, Walter T, Partensky C, Paliard P, Valette PJ, Vuillez JP, Borson-Chazot F, Scoazec JY, Dumortier J.

Ann Nucl Med. 2017 Jun;31(5):379-389. doi: 10.1007/s12149-017-1165-4. Epub 2017 Mar 24.

PMID:
28342103
47.

Tribute to Dr Jacques Rogge: muscle activity and fatigue during hiking in Olympic dinghy sailing.

Bourgois JG, Dumortier J, Callewaert M, Celie B, Capelli C, Sjøgaard G, De Clercq D, Boone J.

Eur J Sport Sci. 2017 Jun;17(5):611-620. doi: 10.1080/17461391.2017.1300328. Epub 2017 Mar 19. Review.

PMID:
28316262
48.

Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.

Costentin CE, Amaddeo G, Decaens T, Boudjema K, Bachellier P, Muscari F, Salamé E, Bernard PH, Francoz C, Dharancy S, Vanlemmens C, Radenne S, Dumortier J, Hilleret MN, Chazouillères O, Pageaux GP, Calderaro J, Laurent A, Roudot-Thoraval F, Duvoux C; Liver Transplantation French Study Group.

Liver Int. 2017 May;37(5):717-726. doi: 10.1111/liv.13388. Epub 2017 Mar 24.

PMID:
28199760
49.

Donor-Related Coccidioidomycosis Transmitted Through Left-Liver Transplant to a Child Recipient in a Nonendemic Area.

Tanné C, Dijoud F, Rabodonirina M, Dupont D, Rivet C, Collardeau-Frachon S, Gillet Y, Dubois R, Hameury F, Dumortier J, Lachaux A.

Pediatr Infect Dis J. 2017 Aug;36(8):805-808. doi: 10.1097/INF.0000000000001560.

PMID:
28134743
50.

Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial.

Saliba F, Duvoux C, Gugenheim J, Kamar N, Dharancy S, Salamé E, Neau-Cransac M, Durand F, Houssel-Debry P, Vanlemmens C, Pageaux G, Hardwigsen J, Eyraud D, Calmus Y, Di Giambattista F, Dumortier J, Conti F.

Am J Transplant. 2017 Jul;17(7):1843-1852. doi: 10.1111/ajt.14212. Epub 2017 Mar 10.

Supplemental Content

Loading ...
Support Center